EPISODE · Mar 21, 2026 · 29 MIN
Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
from Hematologic Oncology Update
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.CME information and select publications here.
NOW PLAYING
Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
No transcript for this episode yet
Similar Episodes
May 27, 2026 ·21m
May 9, 2026 ·18m
Apr 21, 2026 ·9m
Apr 10, 2026 ·42m
Mar 28, 2026 ·24m